BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  SuperGen, Inc. Granted Orphan Drug Designation for MP-470 in Glioblastoma Multiforme

  August 7, 2008

   · 

  4 min read
• Business

  Somaxon Pharmaceuticals, Inc. Appoints Richard W. Pascoe as President and Chief Executive Officer

  August 7, 2008

   · 

  5 min read
• Business

  Isis Pharmaceuticals, Inc. Posts Narrower-Than-Expected Q2 Loss

  August 7, 2008

   · 

  1 min read
• Business

  Sonus Pharmaceuticals, Inc. Signs Exclusive In-Licensing Agreement With Bayer HealthCare AG for Caspase Activator Compounds

  August 7, 2008

   · 

  6 min read
• Deals

  Datascope Corporation Sells Vascular Closure Assets of Its Interventional Products Business

  August 7, 2008

   · 

  2 min read
• Drug Development

  IMPAX Laboratories, Inc. Reports Positive Results in Phase III Trial with IPX056

  August 7, 2008

   · 

  3 min read
• Drug Development

  Genzyme Corporation and Isis Pharmaceuticals, Inc. Begin Second Phase 3 Trial Of Mipomersen Broad New Patent Granted

  August 7, 2008

   · 

  9 min read
• Business

  Paragon CEO to Leave Company Within Year; Interim CFO Announced

  August 7, 2008

   · 

  2 min read
• Deals

  Monsanto Company Looking to Divest its BGH Product, Posilac

  August 7, 2008

   · 

  1 min read
• Business

  Cardinal Health, Inc. Profit Beats Estimates, Explores Spin-off

  August 7, 2008

   · 

  14 min read